@mtm-laboratories.com
MTM Laboratories manufactures in-vitro diagnostics for the early-detection and diagnosis of cervical and other cancers.
๐ข
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allIcon
JPEG
About
Description
MTM Laboratories is a German biotechnology company established in 1998 with headquarters in Heidelberg, Germany. Founded by Professor Manfred Dietel and Professor Horst Buerger, the company specializes in developing and commercializing innovative diagnostic products related to cervical cancer and other gynecological diseases. MTM Laboratories is best known for its flagship product, the p16INK4a biomarker, which is used for detecting high-grade lesions and cervical cancer.
This biomarker has become an integral part of cervical cancer screening programs globally. It is a key component in the biomarker-based CINtecยฎ Histology product line, which includes immunohistochemistry and histochemistry assays. These assays aid in the classification of cervical tissue samples and provide crucial diagnostic information to healthcare professionals.
Operating on a global scale, MTM Laboratories has established partnerships and subsidiaries in key regions. The company has a strong presence in Europe, with subsidiary offices and distributors across several countries. MTM Laboratories has also developed strategic partnerships with major healthcare organizations worldwide to facilitate the adoption and distribution of its products.
In terms of market position, MTM Laboratories holds a leading position in the cervical cancer diagnostics market globally. Its innovative products and commitment to improving women's health have garnered recognition and respect from the medical community. The company's sales have shown consistent growth, and it continues to expand its market share through partnerships, joint ventures, and collaborations.
MTM Laboratories has undergone significant developments in recent years. In 2018, Roche acquired MTM Laboratories, enabling the company to benefit from Roche's global distribution network and resources. This takeover has strengthened MTM Laboratories' position in the market and has opened up new opportunities for growth and product development.
As of the latest available information, MTM Laboratories remains a leading player in the field of cervical cancer diagnostics. The company continues to invest in research and development, aiming to bring innovative solutions to the market and make a positive impact on healthcare providers and patients globally. Overall, MTM Laboratories has a strong presence in the global cervical cancer diagnostics market and continues to make significant contributions to improving women's health
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere ๐
All services online
Top brand categories